| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
9,265 |
8,454 |
$3.37M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
587 |
566 |
$841K |
| 70450 |
Computed tomography, head or brain; without contrast material |
840 |
820 |
$520K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,285 |
2,148 |
$427K |
| 80053 |
Comprehensive metabolic panel |
4,657 |
4,191 |
$386K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,930 |
2,633 |
$365K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,835 |
1,695 |
$246K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,505 |
1,428 |
$169K |
| 71045 |
Radiologic examination, chest; single view |
2,457 |
2,333 |
$135K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
807 |
768 |
$131K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
876 |
812 |
$128K |
| 84512 |
|
1,439 |
1,252 |
$116K |
| 81025 |
|
2,101 |
1,862 |
$93K |
| 83690 |
|
1,659 |
1,553 |
$90K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
673 |
651 |
$90K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
833 |
789 |
$87K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,571 |
4,967 |
$81K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,697 |
1,577 |
$75K |
| J3490 |
Unclassified drugs |
4,665 |
2,705 |
$75K |
| 93017 |
|
160 |
143 |
$72K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
498 |
485 |
$69K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
127 |
124 |
$65K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
56 |
55 |
$61K |
| 71046 |
Radiologic examination, chest; 2 views |
788 |
765 |
$59K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
960 |
910 |
$57K |
| 83880 |
|
834 |
802 |
$53K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,261 |
1,204 |
$53K |
| 83605 |
|
950 |
832 |
$49K |
| 76377 |
|
246 |
226 |
$48K |
| 85610 |
|
1,537 |
1,422 |
$38K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
171 |
170 |
$37K |
| 36415 |
Collection of venous blood by venipuncture |
2,329 |
1,962 |
$35K |
| 81003 |
|
2,739 |
2,472 |
$29K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
73 |
72 |
$27K |
| 99199 |
Unlisted special service, procedure or report |
571 |
538 |
$27K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,305 |
2,049 |
$26K |
| 87040 |
|
259 |
143 |
$24K |
| 81001 |
|
1,859 |
1,753 |
$23K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
360 |
352 |
$20K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,039 |
506 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
72 |
69 |
$16K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,017 |
858 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,548 |
1,403 |
$15K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
172 |
166 |
$15K |
| 84484 |
|
624 |
499 |
$14K |
| 87077 |
|
521 |
505 |
$14K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
125 |
108 |
$12K |
| 0250 |
|
1,074 |
718 |
$12K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,063 |
259 |
$11K |
| 80306 |
|
169 |
163 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
551 |
533 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,051 |
999 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
25 |
25 |
$9K |
| 87641 |
|
158 |
150 |
$8K |
| 85379 |
|
151 |
145 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
192 |
190 |
$8K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
72 |
68 |
$8K |
| 94664 |
|
104 |
99 |
$7K |
| 94760 |
|
414 |
398 |
$6K |
| 96376 |
|
162 |
150 |
$6K |
| Z7502 |
|
154 |
147 |
$6K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
219 |
214 |
$6K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
279 |
212 |
$6K |
| 87276 |
|
612 |
600 |
$5K |
| 82948 |
|
584 |
395 |
$5K |
| 0636 |
|
96 |
86 |
$5K |
| 0637 |
|
1,483 |
914 |
$5K |
| 87186 |
|
166 |
163 |
$5K |
| 87275 |
|
607 |
596 |
$4K |
| 87581 |
|
172 |
170 |
$4K |
| 0270 |
|
861 |
508 |
$4K |
| 87486 |
|
171 |
170 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
85 |
75 |
$3K |
| 87430 |
|
115 |
114 |
$3K |
| 87081 |
|
76 |
76 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
229 |
219 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
92 |
26 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
157 |
149 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
158 |
150 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
147 |
141 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
34 |
33 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
137 |
113 |
$1K |
| 85730 |
|
118 |
110 |
$1K |
| 0251 |
|
364 |
340 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$1K |
| 80061 |
Lipid panel |
183 |
182 |
$1K |
| 97161 |
|
12 |
12 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
111 |
96 |
$1K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
44 |
44 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
27 |
26 |
$822.14 |
| 0324 |
|
12 |
12 |
$702.03 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
39 |
38 |
$626.30 |
| 83735 |
|
56 |
47 |
$435.29 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
64 |
63 |
$337.97 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
33 |
29 |
$326.75 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$251.26 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$251.08 |
| 86900 |
|
19 |
12 |
$232.56 |
| 86850 |
|
19 |
12 |
$203.91 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
12 |
$137.83 |
| 86901 |
|
19 |
12 |
$112.30 |
| 84100 |
|
19 |
15 |
$103.27 |
| A9270 |
Non-covered item or service |
13 |
13 |
$0.00 |